Updated:
ScribeAmerica
ScribeAmerica is the largest US medical scribe provider, employing over 20,000 scribes. Founded by Dr. Marc L.
ScribeAmerica
ScribeAmerica was founded in 2004 by Dr. Marc L. Grodman and a small team, initially focused on training scribes for emergency departments—a model that has since expanded to over 70 medical specialties. The wealth origin is Dr. Grodman's stake in the firm, built through bootstrapping and later equity investment from private equity backers. The company is headquartered in Fort Lauderdale, Florida. Strategically, ScribeAmerica generates revenue by providing scribes who accompany physicians in clinical settings, documenting patient encounters in real time. The firm also develops proprietary software for clinical documentation and has acquired several regional competitors, including Aquity Scribe (2021) and ScribeCloud (2023). Its operations span all 50 US states, with a growing presence in Canada through partnerships. Core asset classes include healthcare services, technology-enabled workflow solutions, and real estate for training centers. The firm employs approximately 20,000 scribes (per public record, 2024), making it the largest medical scribe workforce globally. It operates a dedicated technology arm, ScribeAmerica Technologies, which develops AI-assisted documentation tools. In January 2024, ScribeAmerica announced a partnership with Epic Systems to integrate its scribe workflow directly into Epic's electronic health record platform (per the firm, January 2024). Adjacent vehicles include a charitable foundation supporting healthcare access in underserved communities, though disclosure is limited. ScribeAmerica's structural differentiator is its position as a large operating company that also functions as a technology firm—deriving revenue from service contracts while investing in software and AI for clinical documentation. Unlike a traditional asset manager, its capital is deployed to acquire competitors and fund R&D in healthcare AI, creating a vertical integration in the medical scribe market.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Fort Lauderdale
Corporate office
Fort Lauderdale, FL, United States
Sector focus
Frequently asked questions
Who makes investment decisions at ScribeAmerica?
Investment decisions are made by the founding team, led by CEO Dr. Marc L. Grodman, along with senior leadership from the firm's corporate development and finance departments. Specific named investment professionals are not publicly disclosed beyond general executive roles (per the firm's official communications).
How does ScribeAmerica source its acquisition targets?
ScribeAmerica sources acquisitions through a combination of direct outreach to regional scribe firms, relationships with hospital systems that use scribe services, and a dedicated corporate development team that evaluates technology-enabled clinical documentation companies. The firm publicly announced acquisitions of Aquity Scribe in 2021 and ScribeCloud in 2023 (per public filings, 2023).
Is ScribeAmerica a family office or an operating company?
ScribeAmerica is an operating company—a medical scribe service provider—not a family office. Its capital is generated through service contracts, not investment returns. The firm may use retained earnings for internal investment and acquisitions, but it does not manage third-party capital or operate as a family office vehicle.
Does ScribeAmerica participate in fund commitments or only direct deals?
ScribeAmerica participates only in direct acquisitions and internal investments. There is no public record of fund commitments to external managers. The firm's capital deployment is focused on acquiring regional scribe firms and developing proprietary technology platforms for clinical documentation.
What investment stages does ScribeAmerica target?
ScribeAmerica targets mature companies in the medical scribe and clinical documentation space, typically established regional firms. It does not target early-stage startups or venture-stage investments. The firm's acquisitions are structured as outright purchases of controlling stakes, not minority investments.
Which sectors does ScribeAmerica focus on?
ScribeAmerica focuses exclusively on healthcare services, specifically medical scribe outsourcing and clinical documentation technology. It explicitly avoids investments outside healthcare and does not participate in real estate (apart from training centers) or other asset classes. Its technology investments are limited to software that supports its core scribe operations (per the firm's public filings).
How is ScribeAmerica related to private equity backers?
ScribeAmerica has received private equity investment from firms such as Northern Pacific Group, but it retains a founder-led operating structure. The private equity relationship provides capital for acquisitions and operational scaling, but does not convert ScribeAmerica into a family office or asset manager. The firm remains an operating company with a singular focus on medical scribe services.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: